All together, these observations suggest that a better understanding of the regulatory pathways controlling the interactions of 14-3-3s with LRRK2, α-Syn, and Parkin will be crucial to get further insights into the pathogenesis of PD and may serve as a potential target in the search for new therapeutic strategies. The gene discussed is PRKN; the disease is Parkinson disease.